Supernus Pharmaceuticals ... (SUPN)
NASDAQ: SUPN
· Real-Time Price · USD
43.41
1.24 (2.94%)
At close: Aug 15, 2025, 12:10 PM
Supernus Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 144.71M | 115.85M | 69.33M | 31.67M | 52.09M | 63.4M | 75.05M | 94.98M | 24.71M | 58.44M | 93.12M | 111.49M | 173.43M | 115.72M | 203.43M | 215.28M | 223.77M | 255.64M |
Short-Term Investments | 377.88M | 347.74M | 384.28M | 371.54M | 295.1M | 234.34M | 179.82M | 105.2M | 126.95M | 170.13M | 368.21M | 280.3M | 187.36M | 196.49M | 136.25M | 228.57M | 186.07M | 135.46M |
Long-Term Investments | n/a | n/a | n/a | n/a | -11.44M | 11.66M | 16.62M | 25.13M | 37.48M | 54.16M | 93.9M | 131.94M | 147.37M | 125.34M | 119.17M | 405.48M | 445.47M | 416.57M |
Other Long-Term Assets | 6.08M | 29.22M | 31.53M | 26.28M | 8.12M | -10.88M | 8.51M | 3.6M | -5.81M | -9.48M | -95.07M | -16.87M | -11.97M | -13.86M | -95.05M | 5.99M | 7.7M | -1.49M |
Receivables | 140.83M | 145.64M | 142.08M | 145.41M | 152.49M | 147.73M | 144.16M | 141.76M | 136.56M | 143.57M | 165.5M | 164.09M | 158.06M | 145.15M | 148.93M | 133.68M | 137.28M | 127.06M |
Inventory | 44.02M | 49.42M | 54.29M | 63.98M | 68.16M | 75.08M | 77.41M | 83.48M | 90.56M | 91.15M | 91.54M | 83.17M | 84.86M | 88.8M | 85.96M | 60.16M | 58.39M | 50.23M |
Other Current Assets | 31.42M | 28.93M | 36.09M | 27.4M | 23.17M | 23.77M | 16.68M | 23.93M | 44.77M | 403.76M | 15.78M | 24.85M | 21.41M | 22.37M | 27.02M | 30.69M | 33.74M | 17.63M |
Total Current Assets | 738.87M | 687.58M | 686.07M | 640M | 591M | 544.32M | 493.11M | 449.36M | 423.54M | 883.34M | 734.15M | 663.89M | 625.12M | 568.52M | 601.59M | 668.38M | 639.24M | 586.02M |
Property-Plant & Equipment | 32.95M | 11.34M | 11.54M | 11.88M | 40.04M | 42.72M | 42.52M | 13.69M | 14.19M | 14.61M | 15.17M | 15.87M | 16.32M | 17.21M | 16.95M | 16.47M | 17.07M | 37.95M |
Goodwill & Intangibles | 598.33M | 619.14M | 638.93M | 657.17M | 676.66M | 696.77M | 716.91M | 758.17M | 779.41M | 799.52M | 819.48M | 840.14M | 858.82M | 879.46M | 902.21M | 424.58M | 430.59M | 436.65M |
Total Long-Term Assets | 643.54M | 659.71M | 682M | 702.7M | 724.83M | 759.77M | 915.86M | 835.8M | 869.56M | 908.47M | 968.36M | 1.03B | 1.07B | 1.07B | 1.09B | 886.66M | 933.82M | 921.42M |
Total Assets | 1.38B | 1.35B | 1.37B | 1.34B | 1.32B | 1.3B | 1.41B | 1.29B | 1.29B | 1.79B | 1.7B | 1.69B | 1.69B | 1.64B | 1.69B | 1.56B | 1.57B | 1.51B |
Account Payables | 8.21M | 7.07M | 4.59M | 6.39M | 4.63M | 14.4M | 1.96M | 3.39M | 4.4M | 11.54M | 10.54M | 16.02M | 35.52M | 12.32M | 9.33M | 9.13M | 7.23M | 5.95M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 229.07M | 219.45M | n/a | 49.81M | 58.16M | 236.2M | n/a | 85.36M | 126.14M | 167.7M | 124.49M |
Short-Term Debt | 7.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 484.89M | 401.97M | 401.44M | 400.91M | n/a | 7.24M | n/a | n/a | 5.78M |
Other Current Liabilities | 250.29M | 52.34M | 68.56M | 255.6M | 109.46M | 120.47M | 113.64M | 100.93M | 72.01M | 52.49M | 251.69M | 95.08M | 92.98M | 90.18M | 92.86M | 63.79M | 62.74M | 69.36M |
Total Current Liabilities | 286.36M | 281.77M | 292.4M | 291.51M | 308.66M | 314.55M | 290.2M | 287.53M | 252.59M | 731.54M | 687.96M | 725.99M | 735.54M | 284.56M | 315.38M | 234.71M | 283.45M | 240.81M |
Long-Term Debt | 24.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.36M | 404.17M | 379.25M | 382.93M | 380.41M | 377.8M |
Other Long-Term Liabilities | 7.76M | 7.46M | 7.6M | 15.12M | 7.99M | 7.88M | 7.8M | 16.37M | 42.12M | 61.93M | 42.54M | 20.15M | 20.25M | 19.61M | 52.02M | 55.53M | 87.48M | 55.61M |
Total Long-Term Liabilities | 32.14M | 34.81M | 39.94M | 44.04M | 49.72M | 60.37M | 197.26M | 85.44M | 120.6M | 148.11M | 128.35M | 114.34M | 118M | 526.51M | 557.92M | 509.86M | 504.03M | 512.19M |
Total Liabilities | 318.5M | 316.58M | 332.34M | 335.55M | 358.38M | 374.92M | 487.46M | 372.97M | 373.19M | 879.66M | 816.3M | 840.33M | 853.54M | 811.07M | 873.3M | 744.57M | 787.48M | 753M |
Total Debt | 31.77M | 32.3M | 34.27M | 38.15M | 39.98M | 42.13M | 41.53M | 42.32M | 42.2M | 517.37M | 437.97M | 437.47M | 445.03M | 446.41M | 420.55M | 412.05M | 406.53M | 394.57M |
Common Stock | 56K | 56K | 56K | 55K | 55K | 55K | 55K | 55K | 55K | 54K | 54K | 54K | 53K | 53K | 53K | 53K | 53K | 53K |
Retained Earnings | 567.1M | 544.6M | 556.43M | 541.1M | 502.6M | 482.69M | 482.56M | 481.39M | 497.36M | 498.19M | 481.25M | 455.76M | 454.01M | 446.15M | 379.92M | 377.48M | 355.92M | 332.19M |
Comprehensive Income | -200K | -159K | -189K | 78K | -372K | -534K | -593K | -1.21M | -1.77M | -2.33M | -3.21M | -4.05M | -2.22M | -773K | 1.54M | 4.21M | 5.43M | 6.25M |
Shareholders Equity | 1.06B | 1.03B | 1.04B | 1.01B | 957.45M | 929.17M | 921.52M | 912.19M | 919.91M | 912.15M | 886.2M | 852.8M | 841.43M | 828.45M | 815.85M | 810.47M | 785.58M | 754.44M |
Total Investments | 377.88M | 347.74M | 384.28M | 371.54M | 295.1M | 246M | 196.44M | 130.33M | 164.43M | 224.28M | 462.11M | 412.23M | 334.73M | 321.82M | 255.41M | 634.05M | 631.54M | 552.02M |